These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12433348)

  • 1. [How and why should adherence to antiretroviral therapy].
    Knobel H
    Enferm Infecc Microbiol Clin; 2002 Dec; 20(10):481-3. PubMed ID: 12433348
    [No Abstract]   [Full Text] [Related]  

  • 2. [Factors predicting lack of adherence to highly active antiretroviral treatment].
    Martín-Sánchez V; Ortega-Valín L; Pérez-Simón Mdel R; Mostaza-Fernández JL; Ortiz de Urbina-González JJ; Rodríguez-María M; Carro-Fernández JA; Cuevas-González MJ; Alcoba-Leza M;
    Enferm Infecc Microbiol Clin; 2002 Dec; 20(10):491-7. PubMed ID: 12433350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of three methods to calculate adherence in patients receiving antiretroviral treatment].
    Codina C; Martínez M; Tuset M; del Cacho E; Martín MT; Miró JM; Mallolas J; de Lazzari E; García F; Martínez E; Gatell JM; Ribas J
    Enferm Infecc Microbiol Clin; 2002 Dec; 20(10):484-90. PubMed ID: 12433349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to antiretroviral therapy in pediatric patients with human immunodeficiency virus (HIV-1).
    Burack G; Gaur S; Marone R; Petrova A
    J Pediatr Nurs; 2010 Dec; 25(6):500-4. PubMed ID: 21035017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing clinic retention between residents and nonresidents of Kibera, Kenya.
    Chung MH; Kohler P; Attwa M; Thiga J; John-Stewart GC
    J Acquir Immune Defic Syndr; 2010 Mar; 53(3):422-4. PubMed ID: 20190592
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adherence to the antiretroviral treatment].
    Barreiro García P; González Lahoz J; Soriano Vázquez V
    Rev Clin Esp; 2003 Jun; 203(6):299-302. PubMed ID: 12783718
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of adherence to highly active antiretroviral therapy.
    Martín-Fernández J; Escobar-Rodríguez I; Campo-Angora M; Rubio-García R
    Arch Intern Med; 2001 Dec 10-24; 161(22):2739-40. PubMed ID: 11732942
    [No Abstract]   [Full Text] [Related]  

  • 8. Patients who return to care after tracking remain at high risk of attrition: experience from a large HIV clinic, Uganda.
    Nakiwogga-Muwanga A; Musaazi J; Katabira E; Worodria W; Talisuna SA; Colebunders R
    Int J STD AIDS; 2015 Jan; 26(1):42-7. PubMed ID: 24648320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory monitoring of HIV.
    Lingham P
    S Afr Med J; 2002 Mar; 92(3):173. PubMed ID: 12040928
    [No Abstract]   [Full Text] [Related]  

  • 10. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
    Pozniak A; Gazzard B; Anderson J; Babiker A; Churchill D; Collins S; Fisher M; Johnson M; Khoo S; Leen C; Loveday C; Moyle G; Nelson M; Peter B; Phillips A; Pillay D; Wilkins E; Williams I; Youle M;
    HIV Med; 2003 Oct; 4 Suppl 1():1-41. PubMed ID: 14511246
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy.
    Sullivan PS; Campsmith ML; Nakamura GV; Begley EB; Schulden J; Nakashima AK
    PLoS One; 2007 Jun; 2(6):e552. PubMed ID: 17579723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinuation of antiretroviral therapy postpartum: no evidence for altered viral set point.
    Tungsiripat M; Drechsler H; Aberg JA
    J Acquir Immune Defic Syndr; 2007 Jan; 44(1):116-7. PubMed ID: 17195738
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
    J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study.
    Martin M; Del Cacho E; Codina C; Tuset M; De Lazzari E; Mallolas J; Miró JM; Gatell JM; Ribas J
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1263-8. PubMed ID: 18834323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting and monitoring antiretroviral adherence.
    Gross R
    LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Which antiretroviral strategy to use in adults?].
    Tonnerre P
    Rev Infirm; 2003 Sep; (93):12-6. PubMed ID: 14593983
    [No Abstract]   [Full Text] [Related]  

  • 17. Knowledge of and adherence to antiretroviral therapy.
    Parienti JJ
    Clin Infect Dis; 2003 Sep; 37(6):861-2; author reply 862-3. PubMed ID: 12955656
    [No Abstract]   [Full Text] [Related]  

  • 18. Adherence to antiretroviral therapy.
    J Acquir Immune Defic Syndr; 2002 Dec; 31 Suppl 3():S95-169. PubMed ID: 12580149
    [No Abstract]   [Full Text] [Related]  

  • 19. Lifetime HIV antiretroviral therapy adherence intervention: timing is everything: comment on "Managed problem solving for antiretroviral therapy adherence".
    Bangsberg DR; Haberer JE
    JAMA Intern Med; 2013 Feb; 173(4):306-7. PubMed ID: 23358810
    [No Abstract]   [Full Text] [Related]  

  • 20. High rate of discontinuations of highly active antiretroviral therapy as a result of antiretroviral intolerance in clinical practice: missed opportunities for adherence support?
    Park-Wyllie LY; Scalera A; Tseng A; Rourke S
    AIDS; 2002 May; 16(7):1084-6. PubMed ID: 11953481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.